VSHP Webinar 

Thursday, June 15, 2023 – 12:00pm-1:00 pm

Keeping Up with KDIGO - Preventing Chronic Kidney Disease Progression in Type 2 Diabetes Mellitus

Speaker:

Edidiong Demuren, Pharm.D., MPH

PGY2 Ambulatory Care Pharmacy Resident

Inova

Objectives for Pharmacists:

•       Explain the pathophysiology of Chronic Kidney Disease (CKD) in patients with Type 2 Diabetes Mellitus (T2DM).

•       Employ appropriate therapeutic plans to prevent CKD progression in T2DM.

•       Apply appropriate monitoring strategies for patients receiving finerenone therapy.

•       Evaluate lifestyle modifications recommended by the KDIGO guidelines for preventing the progression of CKD.

•       Recognize the trials that support the use of Sodium-glucose cotransporter 2 inhibitors (SGLT2 inhibitors) and Mineralocorticoid Receptor Antagonists (MRAs) in patients with T2DM and CKD.

Objectives for Pharmacy Technicians:

•       Discuss the pathophysiology of Chronic Kidney Disease (CKD) in patients with Type 2 Diabetes Mellitus (T2DM).

•       List appropriate therapeutic plans to prevent CKD progression in T2DM.

•       Recite appropriate monitoring strategies for patients receiving finerenone therapy.

•       Evaluate lifestyle modifications recommended by the KDIGO guidelines for preventing the progression of CKD.

Accreditation:

Virginia Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider for continuing pharmacy education and has assigned 1.0 contact hour (0.1 CEU) of continuing pharmacy education credits for participating in this activity.

ACPE UAN:  0108-0000-23-044-L01-P; 0108-0000-23-044-L01-T

Activity type: Knowledge-based

This is a member service of VSHP.  There is no charge for members to attend.  Dues must be current to receive CE credit.

Non-members will be charged $20.

To register:  https://us02web.zoom.us/webinar/register/WN_BennYm26RtGAp3OLUQbvHg